Coinbase shares reached a new high in the last 20 months, rising to $162 on December 19, 2023. Over the past year, this stock has posted a remarkable 348% gain.
Shares of the Coinbase cryptocurrency exchange showed growth of 348% in 2023, according to the TraidingView .
According to available information, on December 19, 2023, the COIN ticker immediately reached the level of $162. At the time of writing, the company's shares are trading at $161.
Thus, the securities of the cryptocurrency exchange reached a 20-month high. In December 2023 alone, shares increased in price by 66%. Coinbase's market capitalization, in turn, reached $38.6 billion.
Against the backdrop of rising asset prices, ARK Invest continues to sell shares of Coinbase. Between December 11 and December 17, 2023, the investment firm sold $59 million in exchange-traded securities.
However, Coinbase CEO Brian Armstrong believes that the cryptocurrency market has recovered after a significant correction. He called digital assets “the money of the future”, used by 425 million people.
On December 18, 2023, it was reported that Coinbase and other industry players supported the Super PAC Fairshake. The firms provided the organization with $78 million, which will be used to support pro-cryptocurrency candidates in the 2024 US Congress.
In 2022, the Ukrainian Student League (USL) collaborated with the Rassvet Foundation, founded by Russian oligarch Mikhail…
In Russia, managers and employees of a “branch” of an international network of call centers were exposed. This was reported by RBC-Ukraine...
Mikhail Zhernakov is one of the most public figures in the field of judicial reform in Ukraine, which...
The ministry spent tens of millions on printing unnecessary books in “its” publishing houses. The Ministry of Culture during...
Over more than 30 years of independence, at least $100 billion has been withdrawn from Ukraine abroad,...
Remember the former head of the Tax Service of Ukraine, Roman Nasirov, who wrapped himself in a blanket, pretending to be seriously ill in...
This website uses cookies.